Moberg Pharma publishes bond prospectus and applies for listing of its bond loan on Nasdaq Stockholm
STOCKHOLM, February 23rd 2016. Moberg Pharma AB (publ) (”Moberg Pharma” or ”the company", OMX: MOB) publishes a bond prospectus and applies for listing on Nasdaq Stockholm of its bond loan.On January 25th 2016, Moberg Pharma announced that the company has issued a senior unsecured bond loan in the amount of SEK 300 million within a total framework amount of SEK 600 million. The bond loan will mature on January 29th 2021 and carries an annual interest rate of STIBOR (3 months) + 6.00 percentage points. The company has applied for listing of the bon loan on Nasdaq Stockholm and the first